Biologics CDMO Global Market Report 2024

Biologics CDMO Global Market Report 2024

Including: 1) By Cell Type: Mammalian; Non-Mammalian2) By Product Type: Biologics; BiosimilarsCovering: AbbVie Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Evonik Industries AG; Sandoz International GmbH


Biologics CDMO Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics CDMO market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for biologics CDMO ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics CDMO market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Cell Type: Mammalian; Non-Mammalian

2) By Product Type: Biologics; Biosimilars

Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Evonik Industries AG; Sandoz International GmbH

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biologics CDMO Market Characteristics
3. Biologics CDMO Market Trends And Strategies
4. Biologics CDMO Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Biologics CDMO Market Size and Growth
5.1. Global Biologics CDMO Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Biologics CDMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biologics CDMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Biologics CDMO Market Segmentation
6.1. Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mammalian
Non-Mammalian
6.2. Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biologics
Biosimilars
7. Biologics CDMO Market Regional And Country Analysis
7.1. Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Biologics CDMO Market
8.1. Asia-Pacific Biologics CDMO Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Biologics CDMO Market
9.1. China Biologics CDMO Market Overview
9.2. China Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Biologics CDMO Market
10.1. India Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Biologics CDMO Market
11.1. Japan Biologics CDMO Market Overview
11.2. Japan Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Biologics CDMO Market
12.1. Australia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Biologics CDMO Market
13.1. Indonesia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Biologics CDMO Market
14.1. South Korea Biologics CDMO Market Overview
14.2. South Korea Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Biologics CDMO Market
15.1. Western Europe Biologics CDMO Market Overview
15.2. Western Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Biologics CDMO Market
16.1. UK Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Biologics CDMO Market
17.1. Germany Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Biologics CDMO Market
18.1. France Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Biologics CDMO Market
19.1. Italy Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Biologics CDMO Market
20.1. Spain Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Biologics CDMO Market
21.1. Eastern Europe Biologics CDMO Market Overview
21.2. Eastern Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Biologics CDMO Market
22.1. Russia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Biologics CDMO Market
23.1. North America Biologics CDMO Market Overview
23.2. North America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Biologics CDMO Market
24.1. USA Biologics CDMO Market Overview
24.2. USA Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Biologics CDMO Market
25.1. Canada Biologics CDMO Market Overview
25.2. Canada Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Biologics CDMO Market
26.1. South America Biologics CDMO Market Overview
26.2. South America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Biologics CDMO Market
27.1. Brazil Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Biologics CDMO Market
28.1. Middle East Biologics CDMO Market Overview
28.2. Middle East Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Biologics CDMO Market
29.1. Africa Biologics CDMO Market Overview
29.2. Africa Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Biologics CDMO Market Competitive Landscape And Company Profiles
30.1. Biologics CDMO Market Competitive Landscape
30.2. Biologics CDMO Market Company Profiles
30.2.1. AbbVie Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Thermo Fisher Scientific Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Novartis AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Evonik Industries AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Sandoz International GmbH
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Biologics CDMO Market Other Major And Innovative Companies
31.1. ICON PLC
31.2. Grifols SA
31.3. Lonza Group Ltd.
31.4. Boehringer Ingelheim International GmbH
31.5. Catalent Inc.
31.6. JSR Corp.
31.7. Parexel International Corporation
31.8. WuXi Biologics (Cayman) Inc.
31.9. Samsung Biologics Co. Ltd.
31.10. Emergent BioSolutions Inc.
31.11. Rentschler Biopharma SE
31.12. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
31.13. Binex Co. Ltd.
31.14. Bora Pharmaceuticals Co. Ltd
31.15. 3P Biopharmaceuticals s.l.u
32. Global Biologics CDMO Market Competitive Benchmarking
33. Global Biologics CDMO Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biologics CDMO Market
35. Biologics CDMO Market Future Outlook and Potential Analysis
35.1 Biologics CDMO Market In 2028 - Countries Offering Most New Opportunities
35.2 Biologics CDMO Market In 2028 - Segments Offering Most New Opportunities
35.3 Biologics CDMO Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings